Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer

Clinical trial NCT01802749 · UNKNOWN

Trial details

NCT number: NCT01802749
Sponsor: National Cancer Institute, Naples
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Ovarian Cancer

Start date: 2013-11-01
Primary completion: 2023-12-01
Enrollment: 406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.